share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  04/02 18:46
Moomoo AI 已提取核心訊息
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
與百時美施貴寶（BMY）有聯繫的塞繆爾·西奧多·R.II於2024年3月31日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。沒有具體說明塞繆爾與發行人的關係，也沒有提供有關訴訟後持有的股票數量的信息。
與百時美施貴寶（BMY）有聯繫的塞繆爾·西奧多·R.II於2024年3月31日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。沒有具體說明塞繆爾與發行人的關係，也沒有提供有關訴訟後持有的股票數量的信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息